These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer]. Gómez Sáez JM Endocrinol Nutr; 2010 Oct; 57(8):370-5. PubMed ID: 20850397 [No Abstract] [Full Text] [Related]
6. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
7. Follow-up of differentiated thyroid carcinoma. Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026 [TBL] [Abstract][Full Text] [Related]
8. Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning. Wartofsky L J Clin Endocrinol Metab; 2002 Apr; 87(4):1486-9. PubMed ID: 11932269 [No Abstract] [Full Text] [Related]
10. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody. Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613 [TBL] [Abstract][Full Text] [Related]
12. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study. Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265 [TBL] [Abstract][Full Text] [Related]
13. Changing concepts in the management of differentiated thyroid cancer. Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246 [TBL] [Abstract][Full Text] [Related]
14. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. Lee JI; Chung YJ; Cho BY; Chong S; Seok JW; Park SJ Surgery; 2013 Jun; 153(6):828-35. PubMed ID: 23489940 [TBL] [Abstract][Full Text] [Related]
15. [Treatment and follow-up of thyroid cancer]. Välimäki M Duodecim; 1991; 107(6):456-60. PubMed ID: 1364893 [No Abstract] [Full Text] [Related]
16. [Guidelines for the management of differentiated thyroid cancers]. Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S57-72. PubMed ID: 18342281 [No Abstract] [Full Text] [Related]
17. [After care of differentiated thyroid gland carcinoma with special reference to serum thyroglobulin level]. Kanitz W; Böttger IG; Pabst HW; Heidenreich P; Dirr W Rofo; 1987 Sep; 147(3):282-7. PubMed ID: 2823333 [TBL] [Abstract][Full Text] [Related]
18. [Radioiodine therapy for thyroid cancer]. Misaki T Nihon Rinsho; 2007 Nov; 65(11):2049-52. PubMed ID: 18018569 [TBL] [Abstract][Full Text] [Related]